RecruitingNot Applicable

Prospective Study Registry of Peripheral Neuroblastic Tumours Presenting With Spinal Canal Involvement (SCI)

Italy150 participantsStarted 2014-05

Plain-language summary

To describe the natural history of peripheral neuroblastic tumour presenting with SCI and evaluate the combined effects of different risk factors on the eventual neurologic and orthopaedic outcomes

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of peripheral neuroblastic tumour - peripheral neuroblastic tumour (neuroblastoma, ganglioneuroblastoma, ganglioneuroma) presenting with SCI, symptomatic or asymptomatic, independent of disease extension (stage), and clinical course (first diagnosis or relapse/progression) * No previous chemotherapy, except steroids, in the last 6 months * Age \<18 years * Minimal planned follow-up of 5 years * Parent/patient written informed consent (Appendix 1(A,B,C)) Exclusion Criteria: * Invasion of intervertebral foramina only

What they're measuring

prevalence of neurologic consequences

Timeframe: for 5 years

prevalence of orthopedic consequences

Timeframe: for 5 years

prevalence of pain

Timeframe: for 5 years

Trial details

NCT IDNCT02559804

SponsorAssociazione Italiana Ematologia Oncologia Pediatrica

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2029-05

Contact for this trial

Riccardo Haupt, MD

01056363462 riccardohaupt@ospedale-gaslini.ge.it

View on ClinicalTrials.gov More Neuroblastic Tumors trials